Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response


Meningiomas represent 13–26 % of primary intracranial tumors. WHO distinguishes grade I (benign), II (atypical) and III (anaplastic) tumors. The extent of surgery correlates with survival. Clinical benefit and radiological responses have been described in incompletely resected grade I–II or in anaplastic and recurrent tumors following either radiotherapy… (More)
DOI: 10.1007/s11060-015-2016-6


1 Figure or Table

Slides referencing similar topics